Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2019 2
2020 859
2021 1732
2022 1906
2023 1531
2024 910
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,179 results

Results by year

Filters applied: . Clear all
Page 1
New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. Chen Y, et al. Immunology. 2022 Apr;165(4):386-401. doi: 10.1111/imm.13443. Epub 2022 Jan 7. Immunology. 2022. PMID: 34957554 Free article. Review.
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented setback for global economy and health. ...Here, we s
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. Gusev E, et al. Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716. Int J Mol Sci. 2022. PMID: 35163638 Free PMC article. Review.
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome coronavirus
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavir
Insights into new-onset autoimmune diseases after COVID-19 vaccination.
Guo M, Liu X, Chen X, Li Q. Guo M, et al. Autoimmun Rev. 2023 Jul;22(7):103340. doi: 10.1016/j.autrev.2023.103340. Epub 2023 Apr 17. Autoimmun Rev. 2023. PMID: 37075917 Free PMC article. Review.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronav
COVID-19 vaccines adverse events: potential molecular mechanisms.
Lamprinou M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G. Lamprinou M, et al. Immunol Res. 2023 Jun;71(3):356-372. doi: 10.1007/s12026-023-09357-5. Epub 2023 Jan 6. Immunol Res. 2023. PMID: 36607502 Free PMC article. Review.
COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known as SARS-CoV-2. ...Of note, among these vaccines, seven have been fully approved by WHO. However, despite the benefits of COVID-19 vaccination, s
COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known as SARS-CoV-2. ...
Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
Nakashima C, Kato M, Otsuka A. Nakashima C, et al. J Dermatol. 2023 Mar;50(3):280-289. doi: 10.1111/1346-8138.16651. Epub 2023 Jan 13. J Dermatol. 2023. PMID: 36636825
In December 2019, a new infectious pathogen named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Wuhan, China. Transmitted through respiratory droplets, SARS-CoV-2
In December 2019, a new infectious pathogen named severe acute respiratory syndrome coronavirus 2
New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. Gracia-Ramos AE, et al. Cells. 2021 Dec 20;10(12):3592. doi: 10.3390/cells10123592. Cells. 2021. PMID: 34944099 Free PMC article. Review.
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a dysregulation of the immune system with the development of autoimmune phenomena. ...These findings highlight the potential spectrum of systemic and rheumatic autoimmune
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a dysregulation of the immune system wit …
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Gambichler T, et al. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2. J Eur Acad Dermatol Venereol. 2022. PMID: 34661927 Free PMC article. Review.
There is growing evidence that not only the novel coronavirus disease (COVID-19) but also the COVID-19 vaccines can cause a variety of skin reactions. ...Importantly, molecular mimicry exists between SARS-CoV-2 (e.g. …
There is growing evidence that not only the novel coronavirus disease (COVID-19) but also the COVID-19
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.
Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad Kashani H. Seyed Hosseini E, et al. Virology. 2020 Dec;551:1-9. doi: 10.1016/j.virol.2020.08.011. Epub 2020 Sep 24. Virology. 2020. PMID: 33010669 Free PMC article. Review.
Novel coronavirus SARS-CoV-2, designated as COVID-19 by the World Health Organization (WHO) on the February 11, 2020, is one of the highly pathogenic beta-coronaviruses which infects human. ...Currently, antiviral inhibitors of SARS and M …
Novel coronavirus SARS-CoV-2, designated as COVID-19 by the World Health Organization (WHO) on the …
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.
Wack S, Patton T, Ferris LK. Wack S, et al. J Am Acad Dermatol. 2021 Nov;85(5):1274-1284. doi: 10.1016/j.jaad.2021.07.054. Epub 2021 Aug 4. J Am Acad Dermatol. 2021. PMID: 34363909 Free PMC article. Review.
In this review, we present the current evidence related to COVID-19 vaccine safety and efficacy in patients with IMID and review existing recommendations for vaccination against SARS-CoV-2. Given the current evidence, there is minimal concern th …
In this review, we present the current evidence related to COVID-19 vaccine safety and efficacy in patients with IMID and revi …
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues.
Polykretis P, Donzelli A, Lindsay JC, Wiseman D, Kyriakopoulos AM, Mörz M, Bellavite P, Fukushima M, Seneff S, McCullough PA. Polykretis P, et al. Autoimmunity. 2023 Dec;56(1):2259123. doi: 10.1080/08916934.2023.2259123. Autoimmunity. 2023. PMID: 37710966 Free article. Review.
As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccination has been extended to include age groups and naturally immune people with minimal danger of suffering serious complications due to COV
As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccinat …
6,179 results